Table 1.
Disease | Subjects | Ins/Ins | Ins/Del | Del/Del | MAF | HWE | Country | Reference |
---|---|---|---|---|---|---|---|---|
P value | ||||||||
T2DM | Controls | 94 | 3 | 1 | 0.03 | 1.42×10-4 | Turkey | (6) |
Cases | 74 | 14 | 12 | 0.19 | 4.99×10-8 | |||
Parkinson’s disease | Controls | 95 | 21 | 2 | 0.11 | 0.511 | Greece | (9) |
Cases | 156 | 52 | 7 | 0.15 | 0.309 | |||
VIH susceptibility | Controls | 189 | 65 | 3 | 0.14 | 0.318 | Spain | (7) |
Cases | 160 | 18 | 0 | 0.05 | 0.477 | |||
General population | Controls | 208 | 85 | 11 | 0.18 | 0.531 | Poland | (10) |
Gastric cancer | Controls | 75 | 65 | 8 | 0.27 | 0.202 | Japan | (11) |
Cases | 126 | 112 | 51 | 0.37 | 4.1×10-3 | |||
Alzheimer’s disease | Controls | 172 | 168 | 60 | 0.36 | 0.077 | China | (12) |
Cases | 150 | 161 | 89 | 0.42 | 4.37×10-4 | |||